Rectal Cancer Clinical Trial
Official title:
Bowel Preparation With Nutritional Drinks Instead of Traditional Bowel Preparation Before Rectal Cancer Surgery
Traditionally bowel preparation before surgery of rectal cancer could be troublesome for
patients especially for patients with kidney and cardio- vascular diseases, where salt and
electrolyte balance can be a problem.
Cleaning the bowel without complications for the patient is one of the aims for this study.
The other aim is to see if patient nutritional status improves with nutritional drinks as a
complement to food intake 4-6 weeks before surgery.
In our institution, patients undergoing surgery for cancer in the rectum are often prepared
with energy drinks in order to receive a higher energy level before the operation. As a
result of this the patients often avoid nausea and have a better intestinal function after
surgery and less complications. We think that this treatment has worked well on the patients
but no scientific studies have been done on these patients. As a complementary result of the
treatment with nutritional drinks we have found that the colon is empty already after a
short time of treatment.
The actual study's purpose is to find out if rectal cancer surgery can be performed without
traditionally bowel preparation. Nutritional drinks are to be used instead of traditional
bowel preparation. Patients are randomized into two groups, stratification for stricture,
malnutrition and laparoscopic surgery and each group should either bee treated with
traditional bowel preparation, Laxabon® (A) or nutritional drinks, Fresubin Energy drink (B)
before surgery. Patients in subgroup B take nutritional drinks seven days before surgery
instead of ordinary food. Bowel purity degree is measured peroperatively.
The secondary aim is to see if malnutrition can be improved with nutritional drinks as a
complement to ordinary food intake before surgery. For four to six weeks before surgery 50 %
or more of the caloric need is substituted with nutritional drinks in subgroup B (Fresubin
Energy drink 15-30 kcal/kg*day). Subgroup A only eats ordinary food throughout the same
period, before surgery.
Bowel purity degree, physiological functions, and body mass index are measured in all four
groups before and after surgery. All patients in the study keep records of physical activity
daily, and food diary twice a week. Complications are registered.
Blood samples for hormones and electrolytes are taken before and after surgery.
;
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06380101 -
Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
|
N/A | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Recruiting |
NCT04323722 -
Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
Active, not recruiting |
NCT01347697 -
Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer
|
N/A | |
Recruiting |
NCT04495088 -
Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer
|
Phase 3 | |
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT03520088 -
PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS
|
N/A | |
Recruiting |
NCT05556473 -
F-Tryptophan PET/CT in Human Cancers
|
Phase 1 | |
Recruiting |
NCT04749381 -
The Role of TCM on ERAS of Rectal Cancer Patients
|
Phase 2 | |
Enrolling by invitation |
NCT05028192 -
Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
|
||
Recruiting |
NCT03283540 -
Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
|
||
Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
Recruiting |
NCT05914766 -
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
|
N/A | |
Recruiting |
NCT04852653 -
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
|
||
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A | |
Terminated |
NCT02933944 -
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
|
Phase 1 |